156 related articles for article (PubMed ID: 18427277)
1. Novel transient outward and ultra-rapid delayed rectifier current antagonist, AVE0118, protects against ventricular fibrillation induced by myocardial ischemia.
Billman GE; Kukielka M
J Cardiovasc Pharmacol; 2008 Apr; 51(4):352-8. PubMed ID: 18427277
[TBL] [Abstract][Full Text] [Related]
2. AVE0118, blocker of the transient outward current (I(to)) and ultrarapid delayed rectifier current (I(Kur)), fully restores atrial contractility after cardioversion of atrial fibrillation in the goat.
de Haan S; Greiser M; Harks E; Blaauw Y; van Hunnik A; Verheule S; Allessie M; Schotten U
Circulation; 2006 Sep; 114(12):1234-42. PubMed ID: 16940189
[TBL] [Abstract][Full Text] [Related]
3. Blockade of atrial-specific K+-currents increases atrial but not ventricular contractility by enhancing reverse mode Na+/Ca2+-exchange.
Schotten U; de Haan S; Verheule S; Harks EG; Frechen D; Bodewig E; Greiser M; Ram R; Maessen J; Kelm M; Allessie M; Van Wagoner DR
Cardiovasc Res; 2007 Jan; 73(1):37-47. PubMed ID: 17157284
[TBL] [Abstract][Full Text] [Related]
4. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
Billman GE; Hamlin RL
J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218
[TBL] [Abstract][Full Text] [Related]
5. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs.
Billman GE; Englert HC; Schölkens BA
J Pharmacol Exp Ther; 1998 Sep; 286(3):1465-73. PubMed ID: 9732412
[TBL] [Abstract][Full Text] [Related]
6. The effect of adrenergic receptor antagonists on cocaine-induced ventricular fibrillation: alpha but not beta adrenergic receptor antagonists prevent malignant arrhythmias independent of heart rate.
Billman GE
J Pharmacol Exp Ther; 1994 Apr; 269(1):409-16. PubMed ID: 7909562
[TBL] [Abstract][Full Text] [Related]
7. Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block.
Oros A; Volders PG; Beekman JD; van der Nagel T; Vos MA
Heart Rhythm; 2006 Nov; 3(11):1339-45. PubMed ID: 17074641
[TBL] [Abstract][Full Text] [Related]
8. Effect of calcium channel antagonists on cocaine-induced malignant arrhythmias: protection against ventricular fibrillation.
Billman GE
J Pharmacol Exp Ther; 1993 Jul; 266(1):407-16. PubMed ID: 8331569
[TBL] [Abstract][Full Text] [Related]
9. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
Timour Q; Freysz M; Aupetit JF; Loufoua J; Frassati D; Faucon G
Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
[TBL] [Abstract][Full Text] [Related]
10. Effects of a novel cardioselective ATP-sensitive potassium channel antagonist, 1-[[5-[2-(5-chloro-o-anisamido)ethyl]-beta-methoxyethoxyphenyl]sulfonyl]-3-methylthiourea, sodium salt (HMR 1402), on susceptibility to ventricular fibrillation induced by myocardial ischemia: in vitro and in vivo studies.
Billman GE; Houle MS; Englert HC; Gögelein H
J Pharmacol Exp Ther; 2004 Apr; 309(1):182-92. PubMed ID: 14722326
[TBL] [Abstract][Full Text] [Related]
11. Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs.
Wirth KJ; Paehler T; Rosenstein B; Knobloch K; Maier T; Frenzel J; Brendel J; Busch AE; Bleich M
Cardiovasc Res; 2003 Nov; 60(2):298-306. PubMed ID: 14613859
[TBL] [Abstract][Full Text] [Related]
12. Possible prevention by amlodipine of ventricular fibrillation related to brief ischemia episodes.
Timour Q; Aupetit JF; Freysz M; Frassati D; Faucon G
Can J Physiol Pharmacol; 1996 Dec; 74(12):1308-14. PubMed ID: 9047040
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus attenuates the repolarization reserve in mammalian heart.
Lengyel C; Virág L; Bíró T; Jost N; Magyar J; Biliczki P; Kocsis E; Skoumal R; Nánási PP; Tóth M; Kecskeméti V; Papp JG; Varró A
Cardiovasc Res; 2007 Feb; 73(3):512-20. PubMed ID: 17182020
[TBL] [Abstract][Full Text] [Related]
14. Ephedrine increases ventricular arrhythmias in conscious dogs after myocardial infarction.
Adamson PB; Suarez J; Ellis E; Kanaly T; Vanoli E
J Am Coll Cardiol; 2004 Oct; 44(8):1675-8. PubMed ID: 15489103
[TBL] [Abstract][Full Text] [Related]
15. Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study.
Vaillant F; Timour Q; Descotes J; Manati W; Belhani D; Bui-Xuan B; Tabib A; Bricca G; Chevalier P
J Cardiovasc Pharmacol; 2008 Dec; 52(6):548-54. PubMed ID: 19034029
[TBL] [Abstract][Full Text] [Related]
16. Thoracic spinal cord stimulation reduces the risk of ischemic ventricular arrhythmias in a postinfarction heart failure canine model.
Issa ZF; Zhou X; Ujhelyi MR; Rosenberger J; Bhakta D; Groh WJ; Miller JM; Zipes DP
Circulation; 2005 Jun; 111(24):3217-20. PubMed ID: 15956128
[TBL] [Abstract][Full Text] [Related]
17. Effects of transient myocardial ischemia on the ventricular defibrillation threshold.
Anastasiou-Nana MI; Tsagalou EP; Charitos C; Siafakas KX; Drakos S; Terrovitis JV; Ntalianis A; Doufas A; Mavrikakis J; Nanas JN
Pacing Clin Electrophysiol; 2005 Feb; 28(2):97-101. PubMed ID: 15679638
[TBL] [Abstract][Full Text] [Related]
18. Cardiac-specific overexpression of the human type 1 angiotensin II receptor causes delayed repolarization.
Rivard K; Paradis P; Nemer M; Fiset C
Cardiovasc Res; 2008 Apr; 78(1):53-62. PubMed ID: 18245065
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the cardiac late sodium current with eleclazine protects against ischemia-induced vulnerability to atrial fibrillation and reduces atrial and ventricular repolarization abnormalities in the absence and presence of concurrent adrenergic stimulation.
Justo F; Fuller H; Nearing BD; Rajamani S; Belardinelli L; Verrier RL
Heart Rhythm; 2016 Sep; 13(9):1860-7. PubMed ID: 27317981
[TBL] [Abstract][Full Text] [Related]
20. Analysis of electropharmacological effects of AVE0118 on the atria of chronic atrioventricular block dogs: characterization of anti-atrial fibrillatory action by atrial repolarization-delaying agent.
Kambayashi R; Hagiwara-Nagasawa M; Ichikawa T; Goto A; Chiba K; Nunoi Y; Izumi-Nakaseko H; Matsumoto A; Takahara A; Sugiyama A
Heart Vessels; 2020 Sep; 35(9):1316-1322. PubMed ID: 32346771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
